Stockscreener 앱 받기
58.45
1.33%
0.81
Haemonetics Corp 주식(HAE)의 최신 뉴스
Haemonetics Releases 2024-2025 Corporate Responsibility Report - TipRanks
5 Revealing Analyst Questions From Haemonetics's Q4 Earnings Call - Finviz
Skylands Capital LLC Has $3.97 Million Stock Holdings in Haemonetics Corporation $HAE - MarketBeat
Haemonetics (HAE) International Revenue Performance Explored - Yahoo Finance
Key Players in the Autotransfusion Systems MarketHaemonetics - openPR.com
Chuck Royce's Strategic Moves: Significant Reduction in Haemonetics Corp - Yahoo Finance
Why Haemonetics (HAE) is a Top Value Stock for the Long-Term - Yahoo Finance
A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $75 to $94 - 富途牛牛
Haemonetics Earnings Call: Strong Core, IVT Drag - TipRanks
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Haemonetics (HAE) and Denali Therapeutics (DNLI) - The Globe and Mail
Why Haemonetics (HAE) Raised 2026 Guidance After Strong Plasma And Tech Results And What It Signals - Yahoo Finance
Haemonetics (HAE) Margin Strength In Q3 2026 Reinforces Earnings Led Bullish Narratives - simplywall.st
Haemonetics Q3 Earnings Call Highlights - MarketBeat
Haemonetics (NYSE:HAE) Trading Down 5.6%Here's What Happened - MarketBeat
Haemonetics stock slides 7% as revenue dip and hospital softness blunt raised outlook - TechStock²
Citigroup Lowers Price Target for Haemonetics (HAE) to $75 | HAE Stock News - GuruFocus
Mizuho Lowers Haemonetics (HAE) Price Target, Maintains Outperfo - GuruFocus
Haemonetics (HAE) Rating Update: Barrington Research Raises Pric - GuruFocus
Haemonetics Q3 Earnings & Revenues Beat, Margins Up, Stock Slips - Yahoo Finance
Haemonetics' (HAE) "Buy" Rating Reaffirmed at BTIG Research - MarketBeat
Haemonetics Corporation (NYSE:HAE) Q3 2026 Earnings Call Transcript - Insider Monkey
Haemonetics price target raised to $94 from $93 at Barrington - TipRanks
Haemonetics (HAE) Valuation Check After Q3 Beat And Higher 2026 Guidance - simplywall.st
HAE Q4 Deep Dive: Plasma Momentum and Hospital Weakness Shape Mixed Results - Finviz
Haemonetics stock maintains Market Outperform rating at Citizens on strong plasma growth - Investing.com Nigeria
Haemonetics stock maintains Market Outperform rating at Citizens on strong plasma growth By Investing.com - Investing.com South Africa
BTIG Reiterates Buy Rating and $88 Price Target on HAE | HAE Sto - GuruFocus
Baird lowers Haemonetics stock price target to $81 on mixed outlook By Investing.com - Investing.com South Africa
Baird lowers Haemonetics stock price target to $81 on mixed outlook - Investing.com Nigeria
Decoding Haemonetics Corp (HAE): A Strategic SWOT Insight - GuruFocus
Haemonetics Q3 2026 slides: Margin expansion and cash flow surge despite revenue transition - Investing.com Canada
Haemonetics (NYSE:HAE) Announces Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
Haemonetics Corp (HAE) Q3 2026 Earnings Call Highlights: Strong - GuruFocus
Haemonetics reports Q3 adjusted EPS $1.31, consensus $1.25 - TipRanks
Haemonetics HAE Q3 2026 Earnings Call Transcript - AOL.com
Haemonetics (HAE) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
Haemonetics (HAE) Exceeds Q3 Revenue Expectations with Strong Pe - GuruFocus
Haemonetics's (NYSE:HAE) Q4 CY2025 Sales Top Estimates, Stock Soars - Finviz
Haemonetics (NYSE:HAE) Releases FY 2026 Earnings Guidance - MarketBeat
Haemonetics (HAE) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance
Haemonetics: Fiscal Q3 Earnings Snapshot - kare11.com
Haemonetics beats Q3 expectations, raises fiscal 2026 guidance By Investing.com - Investing.com Nigeria
Haemonetics beats Q3 expectations, raises fiscal 2026 guidance - Investing.com
Haemonetics’s (NYSE:HAE) Q4 CY2025 Sales Top Estimates, Stock Soars - Yahoo Finance
Haemonetics: Fiscal Third Quarter Earnings Overview - Bitget
Haemonetics earnings beat by $0.06, revenue topped estimates - Investing.com
Haemonetics Corporation Q3 Fiscal 2026 Results - TradingView
HAEMONETICS CORP SEC 10-Q Report - TradingView
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website - PR Newswire
Federated Hermes Inc. Buys 43,042 Shares of Haemonetics Corporation $HAE - MarketBeat
Haemonetics Q3 Earnings: Can Momentum Be Sustained? - AD HOC NEWS
What To Expect From Haemonetics's (HAE) Q4 Earnings - Finviz
What To Expect From Haemonetics’s (HAE) Q4 Earnings - Yahoo Finance UK
HAE: Barrington Research Maintains Rating with $93 Price Target - GuruFocus
Haemonetics (NYSE:HAE) Receives Outperform Rating from Barrington Research - MarketBeat
A Glimpse Into The Expert Outlook On Haemonetics Through 11 Analysts - Benzinga
Earnings Beat And Vivasure Deal Might Change The Case For Investing In Haemonetics (HAE) - simplywall.st
Assessing Haemonetics (HAE) Valuation After Recent Share Price Swings And Margin Expansion Story - Yahoo! Finance Canada
Haemonetics (HAE) Sparks Confidence Following Vivasure Acquisition - Finviz
0.88%
0.76%
자본화:
|
볼륨(24시간):